MetLife Investment Management’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.09M | Buy |
|
|||||
|
2025
Q2 | $457K | Buy |
|
|||||
|
2025
Q1 | $316K | Sell |
|
|||||
|
2024
Q4 | $443K | Buy |
|
|||||
|
2024
Q3 | $576K | Hold |
|
|||||
|
2024
Q2 | $450K | Buy |
|
|||||
|
2024
Q1 | $287K | Sell |
|
|||||
|
2023
Q4 | $252K | Hold |
|
|||||
|
2023
Q3 | $418K | Buy |
|
|||||
|
2023
Q2 | $417K | Buy |
|
|||||
|
2023
Q1 | $367K | Hold |
|
|||||
|
2022
Q4 | $393K | Hold |
|
|||||
|
2022
Q3 | $508K | Buy |
|
|||||
|
2022
Q2 | $211K | Buy |
|
|||||
|
2022
Q1 | $123K | Buy |
|
|||||
|
2021
Q4 | $36.6K | Sell |
|
|||||
|
2021
Q3 | $118K | Buy |
|